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Leptin plays a pivotal role in regulation of energy
balance. Via unknown central pathways, leptin also
affects peripheral glucose homeostasis and loco-
motor activity. We hypothesized that, specifically, pro-
opiomelanocortin (POMC) neurons mediate those
actions. To examine this possibility, we applied
Cre-Lox technology to express leptin receptors
(ObRb) exclusively in POMC neurons of the morbidly
obese, profoundly diabetic, and severely hypoactive
leptin receptor-deficient Leprdb/db mice. Here, we
show that expression of ObRb only in POMC neurons
leads to a marked decrease in energy intake and
a modest reduction in body weight in Leprdb/db
mice. Remarkably, blood glucose levels are entirely
normalized. This normalization occurs independently
of changes in food intake and body weight. In addi-
tion, physical activity is greatly increased despite
profound obesity. Our results suggest that leptin
signaling exclusively in POMC neurons is sufficient
to stimulate locomotion and prevent diabetes in
the severely hypoactive and hyperglycemic obese
Leprdb/db mice.
INTRODUCTION
Leptin, an adipocyte-derived hormone, acts on the central
nervous system to regulate energy balance by activating the
long form of the leptin receptor (ObRb or LEPR-B) (Friedman
and Halaas, 1998). The absence of leptin or leptin receptors in
Lepob/ob mice or Leprdb/db mice, respectively, results in morbid
obesity, hyperphagia, severe hyperglycemia and insulin resis-
tance, and marked hypoactivity (Chen et al., 1996; Coleman,
1978; Lee et al., 1996; Pelleymounter et al., 1995; Tartaglia
et al., 1995; Zhang et al., 1994). Among several leptin-responsive
brain regions, the arcuate nucleus of the hypothalamus (ARC) is
a key area for mediating leptin actions on energy homeostasis.
Consistent with this, leptin receptor mRNA is densely expressed
in the ARC of mice and rats (Elmquist et al., 1998; Mercer et al.,
1996), and injection of leptin directly into the ARC is sufficient to
acutely reduce food intake (Satoh et al., 1997). Moreover, unilat-
eral restoration of leptin receptor expression in the ARC of leptin
receptor-deficient Leprdb/dbmice leads to long-term reduction ofbody weight and food intake (Coppari et al., 2005), and ARC-
specific Lepr gene therapy is sufficient to attenuate the obesity
phenotype of leptin receptor-deficient Koletsky fak/ fak rats
(Morton et al., 2003).
The ARC contains at least two subsets of leptin-responsive
neurons, namely the anorexigenic pro-opiomelanocortin
(POMC) neurons and the orexigenic Agouti-related peptide
(AgRP)neurons.POMCneuronsaredepolarizedby leptin, leading
to release of a-melanocyte-stimulating hormone (a-MSH), a
POMC-derived neuropeptide that mediates its anorexigenic
effects through activation of melanocortin receptors (Cone,
2005; Cowley et al., 2001; Schwartz et al., 2000). AgRP is an
endogenous melanocortin receptor antagonist that potently
stimulates feeding (Ollmann et al., 1997). Consistent with this,
AgRP neurons are inhibited by leptin (van den Top et al., 2004).
Mice lacking leptin receptors only in POMC or AgRP neurons
are mildly obese, demonstrating that both groups of cells are
partly required for maintenance of body-weight homeostasis
by leptin (Balthasar et al., 2004; van de Wall et al., 2007).
In addition to its role in energy homeostasis, leptin can regu-
late peripheral glucose and insulin homeostasis via the central
nervous system. For example, leptin-deficient Lepob/ob mice
exhibit profound diabetes that can be fully prevented by low
doses of leptin that do not affect body weight and food intake
(Pelleymounter et al., 1995). In addition, intracerebroventricular
leptin can acutely stimulate glucose uptake in skeletal muscle
(Cusin et al., 1998; Haque et al., 1999; Kamohara et al., 1997;
Minokoshi et al., 1999) and inhibit hepatic glucose production
(Pocai et al., 2005; van den Hoek et al., 2008). Moreover, leptin
dramatically improves insulin sensitivity in human lipodystrophy
and in lipodystrophic mousemodels, which are characterized by
low serum leptin levels and by severe insulin resistance (Oral
et al., 2002; Petersen et al., 2002; Shimomura et al., 1999).
Genetic studies in mice suggest that the ARC plays a major
role in mediating effects of leptin on glucose balance and on
voluntary locomotor activity (Coppari et al., 2005); however,
the specific arcuate neurons responsible remain unspecified.
Long-term impairment of central melanocortin receptor action
in mice results in marked obesity, hyperinsulinemia, and late-
onset hyperglycemia (Huszar et al., 1997). Insulin resistance
is present before the onset of obesity in melanocortin-4-
receptor-deficient mice (Fan et al., 2000). In addition, ventricular
infusion of a-MSH into rats enhances acute insulin-stimulated
peripheral glucose uptake and reduces hepatic glucose produc-
tion, while a melanocortin receptor antagonist exerts opposite
effects (Obici et al., 2001). Furthermore, loss of glucose sensingCell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc. 537
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Leptin Signaling in POMC NeuronsFigure 1. Generation of Mice Expressing HA-Tagged Leptin Receptors in POMC Neurons
(A) Strategy for generation of HA-ObRb/Pomc-Cre mice.
(B) HA-ObRb-expressing neurons ofHA-ObRb/Pomc-Cremice are located in the ARC, as shown by HA IHC. Right images: highmagnification of areasmarked in
the left two photomicrographs. Arrows indicate examples of HA-positive neurons.
(C) HA-ObRb is expressed in POMC neurons of HA-ObRb/Pomc-Cre mice, as demonstrated by double-fluorescent IHC for HA (red) and b-endorphin (green).
High-magnification images are shown on the right. ARC, arcuate nucleus; 3v, third ventricle; ME, median eminence. Scale bars, 50 mm.by POMC neurons and of glucose-dependent a-MSH release
leads to impaired whole-body glucose tolerance (Parton et al.,
2007). Combined, these studies suggest a role of POMCneurons
and the downstreammelanocortin pathway in influencing periph-
eral insulin sensitivity and glucose balance. However, the extent
to which POMC neuronal action can prevent severe hypergly-
cemia is unknown.
Given that arcuate POMC neurons express leptin receptors
and that both leptin and the melanocortin system can influence
glucose and insulin homeostasis, we hypothesized that POMC
neurons mediate those leptin actions. In addition, yet-unspeci-
fied arcuate neurons can control locomotor activity by leptin.
To that end, we generated mice expressing leptin receptors
exclusively in POMC neurons of the severely diabetic and hypo-
active Leprdb/db mice.
RESULTS
Generation of Mice Expressing Leptin Receptors
in POMC Neurons
Mice expressing HA-tagged ObRb in POMC neurons were
generated by mating HA-ObRb transgenic mice with transgenic
Pomc-Cre mice (Figure 1A). The HA tag at the N terminus of
ObRbwas introduced to facilitate detection of the leptin receptor
protein. To first assess whether HA-ObRb was expressed in
areas known to contain POMC neurons, we performed HA
immunohistochemistry (IHC). As expected, HA immunoreactive
(IR) cells were found in the ARC of HA-ObRb/Pomc-Cre mice
(Figure 1B), but not in brains from HA-ObRb control mice538 Cell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc.(Figure 1B). Double HA and b-endorphin IHC analyses on brains
from three HA-ObRb/Pomc-Cremice showed that 44% (± 12%)
of POMC neurons (3760 ± 440) in each animal expressed
HA-ObRb. This percentage may be underestimated due to
reduced sensitivity of the HA antibody combined with low HA-
ObRb expression. Importantly, the vast majority (87% ± 9%) of
detectable HA IR neurons were POMC neurons (Figure 1C).
The HA tag did not interfere with STAT3 activation by ObRb in
transfected cells (not shown). To determine whether HA-tagged
leptin receptors are also functional in vivo, we generated
mice that express HA-ObRb in POMC neurons but lack endog-
enous long-form receptors (HA-ObRb/Pomc-Cre/Leprdb/db)
and measured leptin-dependent STAT3 phosphorylation in the
brain. As predicted, leptin did not induce P-STAT3 in the hypo-
thalamus of HA-ObRb/Leprdb/db control mice (Figure 2A) or
Pomc-Cre/Leprdb/db control mice (not shown). In leptin-treated
Leprdb/db mice, we counted a baseline of 106 ± 39 P-STAT3 IR
neurons in the entire ARC. In contrast, 1877 ± 612 P-STAT3-
positive cells were found in the arcuate of leptin-treated
HA-ObRb/Pomc-Cre/Leprdb/db mice (Figure 2B) and 9540 ±
885 in wild-type mice (Figure 2C). Importantly, P-STAT3 was
not detected in the ventromedial (VMH), the dorsomedial (DMH),
or the premammillary (PMV) nuclei of HA-ObRb/Pomc-Cre/
Leprdb/db mice, regions known to express P-STAT3 in leptin-
treated wild-type mice (Figure 2C) (Munzberg et al., 2004). A
small group of POMC neurons exists in the nucleus of the solitary
tract (NTS) of the caudal hindbrain (Palkovits and Eskay, 1987).
Despite lack of detectable HA-positive neurons in this region
(not shown), P-STAT3 IR cells were detected in the NTS of
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Leptin Signaling in POMC NeuronsHA-ObRb/Pomc-Cre/Leprdb/db mice (not shown). The expres-
sion of HA-ObRb in the NTS is thus lower compared to the
ARC, but still sufficient to activate STAT3.
Counts of b-endorphin and P-STAT3-positive neurons
(Figure 2D) in leptin-treated HA-ObRb/Pomc-Cre/Leprdb/db
mice showed that 56% (± 24%) of POMC neurons expressed
P-STAT3 and that 88% (± 8%) of the P-STAT3 IR cells were
POMC neurons. Further, 60% (± 5%) of POMC neurons in
leptin-treated wild-type mice and less than 2% of POMC
neurons in Leprdb/db mice expressed P-STAT3. To assess the
expression level of functional HA-ObRb in POMC neurons of
transgenic mice relative to endogenous leptin receptors in
POMC neurons of wild-type mice, leptin-dependent STAT3
phosphorylation in individual POMC neurons was quantified.
We found a 50% decreased level of P-STAT3 in HA-ObRb/
Pomc-Cre/Leprdb/db mice relative to control mice (Figure S1).
These data, combined, demonstrate that HA-ObRb receptors
in POMC neurons are functional in vivo and suggest that
HA-ObRb levels in POMC neurons of transgenic HA-ObRb/
Pomc-Cre/Leprdb/db mice are modestly lower compared to
wild-type mice.
Leptin Signaling in POMC Neurons of Leprdb/db Mice
Reduces Body Weight and Food Intake
Body weights of HA-ObRb/Pomc-Cre/Leprdb/db mice were
slightly decreased (10%–15%) as compared to Leprdb/db mice
but remained greatly increased (65%–90%) relative to wild-type
mice (Figures 3A and 3B). Fat mass and circulating leptin levels
tended toward a modest decrease in HA-ObRb/Pomc-
Figure 2. HA-Tagged Leptin Receptors in
POMC Neurons Are Functional In Vivo
(A–C) Representative photomicrographs of
P-STAT3 IHC in brains from leptin-treated (i.p.
4 mg/kg, 45 min) HA-ObRb/Leprdb/db (A),
HA-ObRb/Pomc-Cre/Leprdb/db (B), and wild-type
(C) mice. Matched medial (top row) and caudal
(bottom row) coronal sections from the medio-
basal hypothalamus are shown. ARC, arcuate
nucleus; DMH, dorsomedial nucleus; VMH,
ventromedial nucleus; PMV, ventral premammil-
lary nucleus. Scale bars, 200 mm.
(D) Leptin activates nuclear P-STAT3 in two POMC
neurons of HA-ObRb/Pomc-Cre/Leprdb/db mice,
as shown by confocal microscopy.
Cre/Leprdb/db mice versus Leprdb/db mice
(Figures 3E and 3F, Table 1). Body length
(Table 1) and leanmass were not different
among these groups (not shown). Food
intake was markedly reduced (30%–
40%) in HA-ObRb/Pomc-Cre/Leprdb/db
mice compared to Leprdb/db control
mice, but remained significantly higher
than wild-type mice (Figures 3C and 3D).
Whole-body energy expenditure as as-
sessed by indirect calorimetry was not
different between HA-ObRb/Pomc-Cre/
Leprdb/dbandLeprdb/dbmice (Table1).The
respiratory exchange ratio was modestly
increased in female but not male HA-ObRb/Pomc-Cre/Leprdb/db
mice relative to Leprdb/db animals. Altogether, the data suggest
that the decreased body weight of HA-ObRb/Pomc-Cre/
Leprdb/dbmice is primarily due to reduced energy intake.
Normalization of Glucose by ObRb in POMC Neurons
in Leprdb/db Mice
Expression of HA-ObRb in POMC neurons of Leprdb/db mice
dramatically improves blood glucose levels. Remarkably, in
5-week-old HA-ObRb/Pomc-Cre/Leprdb/db mice, blood glucose
levels were fully normalized (Figures 4A–4D). This normalization
was also observed in overnight-fasted female and male
HA-ObRb/Pomc-Cre/Leprdb/db mice (not shown). To examine
whether this reduction in circulating glucose in HA-ObRb/
Pomc-Cre/Leprdb/db mice was independent of energy intake,
8-week-old female Leprdb/db mice were pair-fed (30% intake
reduction) to ad libitum-fedHA-ObRb/Pomc-Cre/Leprdb/db litter-
mates for 3 weeks (Figure 4F). As shown in Figure 4E, this food
restriction did not reduce hyperglycemia in Leprdb/db mice.
During the 3 weeks, the average body weight of Leprdb/db mice
fell 3.5 g (42.1 [± 1.9] to 38.6 [± 1.2]). In comparison, ad libitum-
fed Leprdb/db mice with the same age gained 8.6 g (40.4 [± 1.4]
to 49.0 [± 1.2]) during 3 weeks (Figure 3A), altogether demon-
strating that the pair-feeding paradigm greatly impacted the
metabolic status of Leprdb/dbmice and that this alone was insuf-
ficient to attenuate hyperglycemia. Therefore, expression of
leptin receptors in POMC neurons of Leprdb/db mice is sufficient
to correct hyperglycemia independently of changes in energy
intake and body weight.Cell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc. 539
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Leptin Signaling in POMC NeuronsSerum insulin levels were reduced by 60% in HA-ObRb/
Pomc-Cre/Leprdb/db mice compared to Leprdb/db control mice,
but elevated relative to control animals (Figure 4G). Insulin
tolerance was significantly improved in HA-ObRb/Pomc-Cre/
Leprdb/db mice relative to Leprdb/db mice over time (p = 0.021)
and trended toward a decrease (0–30 min) compared to wild-
type mice (p = 0.097) (Figure 4H). In 12-week-old fasted
HA-ObRb/Pomc-Cre/Leprdb/db mice, blood glucose levels were
markedly reduced as compared to Leprdb/db mice (Figure S2A),
despite only a slight decrease inweight (FigureS2B). Fedglucose
was similarly attenuated (not shown). To further assess whether
the reduced glucose levels occurred independently of reduced
body weight, we selected mice from the Leprdb/db and
HA-ObRb/Pomc-Cre/Leprdb/db groups such that the average
body weights of both subgroups were not different (Figure S2D).
Despite equal body weights, glucose remained reduced in
HA-ObRb/Pomc-Cre/Leprdb/db mice (Figure S2C), thus further
supporting the notion that leptin signaling in POMC neurons of
Leprdb/db mice is sufficient to reduce circulating glucose levels
independent of body weight. Expression of HA-ObRb in POMC
neurons of lean non-Leprdb/db mice did not affect body weight
or glucose levels on the mixed (FVB/C57BLKSJ) genetic back-
ground (Figures S3A and S3B). Similarly, HA-ObRb/Pomc-Cre
Figure 3. Expression of HA-ObRb in POMC
Neurons of Leprdb/db Mice Reduces Body
Weight and Food Intake
(A–D) Body-weight curves (A and B) and cumulative
food intake (7–9 weeks) (C and D). Data were collected
from 11 female and 14 male Leprdb/dbmice, 11 female
and 17maleHA-ObRb/Pomc-Cre/Leprdb/dbmice, and
5 female and 9 male wild-type mice.
(E and F) Adipose mass (12 weeks of age). Fat mass
was measured by Echo-MRI in 5 female and 4 male
Leprdb/db mice, 5 female and 7 male HA-ObRb/
Pomc-Cre/Leprdb/db mice, and 8 female and 6 male
wild-type mice. All animals are littermates. *p < 0.05;
**p < 0.01, ***p < 0.001. Error bars are shown as SEM.
mice on a pure FVB background were indis-
tinguishable from wild-type littermates with
regard to body weight, food intake, circu-
lating glucose and insulin, and glucose and
insulin tolerance (Figures S4 and S5).
Leptin Receptors in POMC Neurons
of Leprdb/db Mice Increase Islet Mass
Pancreatic islets in Leprdb/db mice have
altered morphology and impaired function
(Baetens et al., 1978; Leiter et al., 1983). To
indirectly assess islet function in HA-ObRb/
Pomc-Cre/Leprdb/db mice, we investigated
islet morphology, islet size, and total endo-
crinemass (Figure S6). Total endocrinemass
was increased by 2.5-fold in HA-ObRb/
Pomc-Cre/Leprdb/db mice as compared to
both Leprdb/db and wild-type mice and was
caused by increased islet size. The total
number of islets was similar among the three
groups (not shown). Islets from HA-ObRb/Pomc-Cre/Leprdb/db
mice appeared structurally intact. In contrast, Leprdb/db islets
exhibited variable size and irregular morphology. The total islet
mass did not correlate with circulating insulin levels between
Leprdb/db and HA-ObRb/Pomc-Cre/Leprdb/db groups, indicating
differential b cell regulation and/or functionality.
Leptin Receptors in POMC Neurons Increase Activity
Restoration of leptin receptors in arcuate neurons greatly
increases voluntary locomotor activity in Leprdb/dbmice (Coppari
et al., 2005), but the specific neuronsmediating this action remain
unknown. We therefore measured ambulatory movements of
HA-ObRb/Pomc-Cre/Leprdb/db mice and found a remarkable
increase (100%) compared to Leprdb/db mice (Figure 5). The
activity of HA-ObRb/Pomc-Cre/Leprdb/db mice was not statisti-
cally different from lean wild-type mice, although there was
a trend toward a reduction.
Effects of Leptin Signaling in POMC Neurons
on Neuropeptides
HA-ObRb/Pomc-Cre/Leprdb/db mice had modestly increased
hypothalamic POMC mRNA (Figure 6A), consistent with a role
of leptin signaling to stimulate Pomc gene expression (Munzberg540 Cell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc.
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Leptin Signaling in POMC Neuronset al., 2003; Thornton et al., 1997). Moreover, total hypothalamic
a-MSH peptide levels were 3.5-fold increased in HA-ObRb/
Pomc-Cre/Leprdb/db mice relative to Leprdb/db mice and were
similar to wild-type levels (Figure 6D). The increase in a-MSH
was observed both in the arcuate and in POMCfibers innervating
the DMH (Figure 6G). NPY and AgRP neuropeptide levels were
unchanged despite slight changes in AgRP and NPY mRNA
(Figures 6B, 6C, 6E, and 6F).
DISCUSSION
Through actions in the CNS, leptin affects a wide number of bio-
logical systems and processes, including feeding behavior, body
weight balance, neuroendocrine function, insulin sensitivity,
glucose homeostasis, and physical activity, demonstrating plei-
otrophic properties of the hormone. However, little is known
about which specific neuronal groups mediate each of leptin’s
actions. We show here that expression of ObRb only in POMC
neurons is sufficient to correct diabetes and drastically stimulate
locomotor activity of the leptin receptor-deficient Leprdb/dbmice.
Restoration of leptin receptors in arcuate neurons normalizes
blood glucose levels and voluntary locomotor activity in mice
lacking all leptin receptors (Coppari et al., 2005). However, the
specific arcuate neurons responsible remained unspecified.
Here we extend those findings by identifying POMC neurons
as the likely mediators of those effects of leptin. Interestingly,
deletion of ObRb from only POMC neurons of lean mice does
not lead to hyperglycemia (Balthasar et al., 2004) or hypoactivity
(Shi et al., 2008), suggesting that leptin receptors in POMC
neurons are not required for normal regulation of glucose
Table 1. Body Length, O2 Consumption, CO2 Production,
Respiratory Exchange Ratio, Leptin, and Triglycerides
Leprdb/db HA-ObRb/Pomc-Cre/Leprdb/db
Nose/anus length (cm)
Males 10.6 ± 0.2 (5) 10.5 ± 0.2 (7)
Females 10.7 ± 0.1 (7) 10.7 ± 0.1 (8)
Leptin (ng/ml)
Males 100.4 ± 8.5 (17) 91.7 ± 5.4 (12)
Females 106.8 ± 6.7 (11) 96.1 ± 6.9 (11)
Triglycerides (mg/dl)
Males 223.1 ± 21.9 (7) 236.9 ± 33.3 (11)
Females 220.3 ± 19.2 (10) 180.1 ± 21.3 (8)
Respiratory Exchange Ratio (RER)
Males 0.86 ± 0.03 (6) 0.91 ± 0.03 (4)
Females 0.80 ± 0.04 (7) 0.89 ± 0.03 (5) *
VO2 (ml/day)
Males 7639 ± 730 (6) 5844 ± 885 (4)
Females 5566 ± 552 (7) 5408 ± 691 (5)
VCO2 (ml/day)
Males 6613 ± 758 (6) 5335 ± 779 (4)
Females 4406 ± 728 (7) 4984 ± 521 (5)
Serum analyses and body length were measurements in 18-week-old
mice. O2 consumption, CO2 production, and RER were measured at 13
weeks of age. The number of mice per group is shown in parentheses.
*p < 0.05.balance and locomotion. In contrast, our studies demonstrate
that leptin receptor signaling in POMC neurons is sufficient to
exert remarkable control of serum glucose concentrations and
locomotion. These data combined could be explained by the
existence of several groups of leptin-responsive neurons that
are each capable of independently regulating glucose homeo-
stasis and physical activity.
The specific mechanism by which leptin signaling in POMC
neurons leads to normalization of blood glucose is unknown,
but likely involves neuroendocrine processes and/or autonomic
actions. Our data suggest that the normalization is a direct
consequence of leptin action in POMC neurons and is not
secondary to differences in energy consumption or body weight.
Consistent with this, central leptin administration can acutely
increase muscle glucose uptake (Kamohara et al., 1997) and
decrease hepatic glucose production (van den Hoek et al.,
2008) through altered autonomic output (Haque et al., 1999).
Furthermore, the central melanocortin pathway can increase
sympathetic drive to peripheral tissues and enhance insulin-
dependent glucose disposal (Brito et al., 2007; Heijboer et al.,
2005; Rahmouni et al., 2003). Therefore, since HA-ObRb/
Pomc-Cre/Leprdb/db mice have greatly elevated hypothalamic
levels of a-MSH peptides, increased activity of the melanocortin
system may contribute to the normoglycemic phenotype, which
likely results in part from increased insulin sensitivity and
enhanced islet function/capacity. Whether the increased islet
mass is a direct result of leptin action via POMC neurons and
CNS regulation (Imai et al., 2008) or an indirect consequence
of altered metabolic state or incretin action (Karaca et al.,
2009) remains to be elucidated. Moreover, detailed experiments
are required to determine the specific role of the melanocortin
system and the relative contribution of the pancreas and
insulin-sensitive tissues, such as muscle and liver, in the normal-
ization of serum glucose levels.
Exercise training increases insulin sensitivity and improves
glucose homeostasis (Hespel et al., 1996; Ryder et al., 2001). It
is therefore possible that insulin sensitivity and whole-body
glucose balance of HA-ObRb/Pomc-Cre/Leprdb/db mice is
enhanced by the increased physical activity. A role of skeletal
muscle AMP-activated protein kinase (AMPK) in mediating exer-
cise-dependent stimulation of insulin sensitivity and glucose
uptake has been reported (Musi and Goodyear, 2003). In addi-
tion, central administration of melanocortin receptor agonists is
sufficient to activate muscle AMPK phosphorylation in mice
(Tanaka et al., 2007). The extent to which increased locomotion
may contribute to the lowered circulating glucose concentration
remains to be determined.
The marked increase in locomotion of mice expressing ObRb
exclusively in POMC neurons could be due to their improved
metabolic status or to a direct effect of leptin action via POMC
neurons. In favor of the latter possibility, genetically obese
rodents such as melanocortin-4-receptor knockout mice have
reduced physical activity before they become obese (Ste Marie
et al., 2000). In addition, AgRP-deficient mice are hyperactive
(Wortley et al., 2005), and recombinant AgRP decreases loco-
motor activity in normal mice (Tang-Christensen et al., 2004),
further suggesting a role of themelanocortin pathway.Moreover,
deletion of leptin receptors from AgRP neurons results in
a modest reduction in activity (van de Wall et al., 2007), andCell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc. 541
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increases locomotion (Mesaros et al., 2008). We did not find
altered levels of AgRP in HA-ObRb/Pomc-Cre/Leprdb/db mice,
but the increase in hypothalamic a-MSH peptides supports the
possibility of a role of the melanocortin pathway in stimulating
locomotor activity in these mice.
In contrast to the striking effects of leptin signaling in POMC
neurons on blood glucose and locomotor activity in Leprdb/db
mice, regulation of body weight appears only partially mediated
by POMC neurons. At 12 weeks, HA-ObRb/Pomc-Cre/Leprdb/db
mice are 10% lighter relative to mice lacking all leptin
receptors. It is, however, possible that the difference in weight
between HA-ObRb/Pomc-Cre/Leprdb/db and Leprdb/db mice
would be greater if Leprdb/db mice had not been diabetic and
Figure 4. Expression of HA-ObRb in POMC Neurons
of Leprdb/db Mice Normalizes Circulating Glucose
Levels and Increases Insulin Sensitivity
(A and B) Fed glucose levels (A) and body weight (B) of
5-week-old female Leprdb/db mice (n = 7), HA-ObRb/
Pomc-Cre/Leprdb/db mice (n = 8), and wild-type mice (n = 8).
(C and D) Fed glucose levels (C) and body weight (D) of
5-week-old male Leprdb/db mice (n = 11), HA-ObRb/
Pomc-Cre/Leprdb/dbmice (n = 12), and wild-typemice (n = 14).
(E) Glucose levels in food-restricted Leprdb/db mice. Over a
period of 3 weeks, 8-week-old female Leprdb/db mice (n = 4)
were pair-fed to ad libitum-fedHA-ObRb/Pomc-Cre/Leprdb/db
littermates (n = 4). Wild-type littermates (n = 6) were fed ad
libitum.
(F) Cumulative intake over the 3 weeks of pair-feeding.
(G) Fasted serum insulin levels of 12-week-old female
Leprdb/db mice (n = 7), HA-ObRb/Pomc-Cre/Leprdb/db mice
(n = 8), and wild-type mice (n = 8).
(H) Insulin tolerance tests in 13-week-old female Leprdb/db
mice (n = 7), HA-ObRb/Pomc-Cre/Leprdb/db mice (n = 8),
and 4 wild-type mice (*, Leprdb/db versus HA-ObRb/Pomc-
Cre/Leprdb/db). Glucose was administered to wild-type mice
after 30 min to prevent severe hypoglycemia caused by the
high insulin dose (1.5 U/kg). Shown are changes from base-
line. *p < 0.05; **p < 0.01; ***p < 0.001; NS, not significant. Error
bars are shown as SEM.
therefore lost calories through the urine. The contri-
bution of POMC neurons in leptin’s regulation of
body weight might thus be underestimated.
However, our result showing a modest contribution
of POMCneurons on bodyweight is consistent with
data from nondiabetic 12-week-old mice, where
deletion of leptin receptors from POMC neurons
results in a 10% weight increase (Balthasar et al.,
2004). Therefore, both deletion and restoration
data show that leptin signaling elsewhere in the
CNS is required for leptin’s full effect on long-
term body-weight regulation. In further support of
this, deletion of ObRb in the VMH in 12-week-old
mice increases body weight by 10%, and a
combined loss in POMC and VMH neurons
increases weight by 25%, suggesting additive
effects (Dhillon et al., 2006). Further, deletion of
leptin receptors selectively from AgRP neurons
results in a 16% increase in body weight in 8- to
12-week-old mice, and combined ObRb deletion from both
AgRP and POMC neurons increases body weight by 28%
(van de Wall et al., 2007). Body weight regulation by leptin is
therefore likely distributed between several brain nuclei and
cell types, each having partial but additive roles.
We found a marked 30%–40% reduction in energy intake
in mice expressing leptin receptors solely in POMC neurons
relative to Leprdb/db mice, but did not detect changes in whole-
body O2 consumption. The greatly increased locomotor activity
therefore does not appear to significantly impact whole-body
energy expenditure, and the reduction in food intake likely
accounts for the decrease in body weight of HA-ObRb/Pomc-
Cre/Leprdb/db mice. This suggests that POMC neurons play
a partial role in attenuating food intake by leptin, but have little542 Cell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc.
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Leptin Signaling in POMC NeuronsFigure 5. Increased Activity of Leprdb/db Mice Expressing HA-ObRb in POMC Neurons
(A) Examples of locomotor activity from 1 Leprdb/db, 1 HA-ObRb/Pomc-Cre/Leprdb/db, and 1 wild-type mouse. Black bar depicts lights-off period.
(B–D) Average nocturnal (B), diurnal (C), and 24 hr (D) locomotor activity in 13-week-old male Leprdb/db mice (n = 4), HA-ObRb/Pomc-Cre/Leprdb/db mice (n = 6),
and wild-type mice (n = 5). *p < 0.05; NS, not significant. Error bars are shown as SEM.if any independent role in leptin’s action to increase energy
expenditure (Hwa et al., 1997).
In addition to the hypothalamus, a small group of POMC
neurons exists in the NTS of the caudal brainstem (Palkovits
and Eskay, 1987). TheCre-loxP strategy was expected to induce
expression of HA-ObRb both in arcuate and NTS POMC
neurons. Indeed, STAT3 phosphorylation was detected in both
sites of leptin-treated HA-ObRb/Pomc-Cre/Leprdb/db animals.
However, in normal mice, NTS POMC neurons do not appear
respond to leptin, as measured by lack of leptin-inducible
STAT3 phosphorylation (Huo et al., 2006), although another
group reported the opposite results using a similar strategy
(Ellacott et al., 2006). The reason for the discrepancy between
the two studies is yet unclear. Regardless, since leptin receptors
are expressed in NTS neurons of HA-ObRb/Pomc-Cre/Leprdb/db
mice, a possible role of these cells in mediating some of the
phenotypic changes in HA-ObRb/Pomc-Cre/Leprdb/db animals
cannot be excluded. However, restoration of endogenous leptin
receptors solely in the ARC, accomplished by stereotaxic
delivery of adenoviruses expressing FLPe-recombinase in
otherwise leptin-receptor-deficient mice, also results in a partial
reduction in body weight and food intake and a normalization
of serum glucose levels and of locomotor activity (Coppari
et al., 2005). Since these findings are directly comparable to
the phenotype of our HA-ObRb/Pomc-Cre/Leprdb/db mice, we
conclude that arcuate POMC neurons, but not NTS POMC
neurons, are responsible for mediating those effects of leptin.
Approximately 50% of hypothalamic POMC neurons express
functional HA-leptin receptors in the transgenic mice, eventhough the Cre-loxP strategy might have predicted a higher
fraction. The reason for this is unclear. However, we found that
in wild-type mice, only about 60% of POMC neurons respond
to leptin, as measured by STAT3 phosphorylation. Furthermore,
unilateral, not bilateral, restoration of endogenous leptin re-
ceptors in arcuate neurons of leptin-receptor-deficient mice
(Coppari et al., 2005) results in a phenotype strikingly similar
to that of our HA-ObRb/Pomc-Cre/Leprdb/db mice. These data
combined therefore suggest that leptin signaling in 50% of
hypothalamic POMC neurons is sufficient to normalize blood
glucose levels and stimulate physical activity.
In conclusion, our data show that leptin signaling specifically in
hypothalamic POMC neurons is sufficient to correct diabetes
and greatly increase locomotion in Leprdb/db mice, revealing
a remarkable regulatory capacity of POMC neurons.
EXPERIMENTAL PROCEDURES
Animal Care
Animal care and procedures were approved by the Institutional Animal Care
and Use Committee at Beth Israel Deaconess Medical Center. Mice were
housed at 22C–24C using a 14 hr light/10 hr dark cycle with chow food
(Teklad F6 Rodent Diet 8664, Harlan Teklad; Madison, WI).
Generation of HA-ObRb Transgenic Mice
A 6.8 kbHA-ObRb STOP transgene was generated, consisting of the following
elements (50 to 30 ): (1) a 1.6 kb CAG promoter that combines the human cyto-
megalovirus (CMV) enhancer, a chicken b-actin promoter, and the first intron;
(2) a loxP site; (3) a STOP sequence containing a false translational stop
sequence and an SV40 splice donor/poly(A) site; (4) a loxP site; (5) an
HA-taggedmurine leptin receptor (HA-ObRb) cDNA sequence (the HA epitopeCell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc. 543
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Leptin Signaling in POMC NeuronsFigure 6. Hypothalamic POMCmRNA and a-MSH Peptide Levels Are Increased in Leprdb/dbMice Expressing Leptin Receptors Exclusively in
POMC Neurons
(A–C) Arcuate POMC, NPY, and AgRP mRNA from 18-week-old control Leprdb/db mice (n = 7) and HA-ObRb/Pomc-Cre/Leprdb/db mice (n = 5).
(D–F) Hypothalamic a-MSH, NPY, and AgRP neuropeptide levels asmeasured by EIAs in 18-week-old Leprdb/dbmice (n = 3),HA-ObRb/Pomc-Cre/Leprdb/dbmice
(n = 3), and wild-type mice (n = 3). Numbers are depicted as percent of Leprdb/db levels. *p < 0.05; **p < 0.01; NS, not significant.
(G) Representative images of hypothalamic a-MSH immunostaining in 18-week-old HA-ObRb/Pomc-Cre/Leprdb/db and Leprdb/dbmice. Scale bar, 200 mm. Error
bars are shown as SEM.[TyrProTyrAspValProAspTyrAla] was inserted after residue 42 of the leptin
receptor); and (6) a bovine growth hormone poly(A) sequence. Briefly, the
6.8 kb construct was produced by first cloning the HA-ObRb cDNA on
a NotI/HindIII fragment from a plasmid generously given by Dr. J. Flier (Harvard
Medical School; Boston) into pGEM-11Zf(+) (Promega; Madison, WI). The PA
sequence with flanking HindIII and SfiI restriction sites was amplified from
pcDNA3.1Zeo() (Invitrogen; Carlsbad, CA) using the following primer set:
50-CCCAAGCTTAAGTTTAAACCGCTGATCAGC-30 and 50-CCCAAGCTTGGC
CATGCAGGCCGCCATAGAGCCCACCGCATCC-30. It was then cloned into a
HindIII site downstream of the HA-ObRb cDNA. A SalI/NotI fragment encom-
passing the loxP-flanked STOP sequence from plasmid cAct-XstopXnz
(a generous gift fromDr. Anderson, California Institute of Technology; Pasadena,
CA) (Tsien et al., 1996) was then inserted upstream of the HA-ObRb cDNA.
Finally, the CAG promoter isolated from pDRIVE-CAG (InvivoGen; San Diego,
CA) was cloned into a SalI site located upstream of the loxP-flanked STOP
sequence. Transgenic mice were generated by microinjecting the 6.8 kb SfiI
HA-ObRb STOP DNA fragment into fertilized one-cell embryos (FVB strain)
by the transgenic facility at Beth Israel Deaconess Medical Center; Boston.
Generation of HA-ObRb/Pomc-Cre Mice
HA-ObRb transgenic mice (FVB background) were mated with transgenic
Pomc-Cre mice (FVB), which have been described earlier (Balthasar et al.,
2004; van deWall et al., 2007) and were kindly supplied by Dr. Lowell (BIDMC).544 Cell Metabolism 9, 537–547, June 3, 2009 ª2009 Elsevier Inc.Generation of HA-ObRb/Pomc-Cre/Leprdb/db Mice
Leprdb/+ (C57BLKSJ, stock #00642) micewere purchased from Jackson Labo-
ratory (Bar Harbor, ME). HA-ObRb/Pomc-Cre mice (FVB) were then mated
with Leprdb/+ mice. HA-ObRb/Pomc-Cre/Leprdb/db mice were obtained by
intermating of HA-ObRb/Pomc-Cre/Leprdb/+ mice. Only littermates with the
same mixed genetic background (FVB/C57BLKSJ) were compared, except
for Figures S4 and S5, where pure FVB non-Leprdb/db mice were studied.
Materials
Murine leptin was purchased from Dr. E. Parlow (NIDDK; Torrance, CA), and
human insulin was from Eli Lilly (Indianapolis, IN). Supplies for IHC were from
Sigma-Aldrich (St. Louis) and the ABC VECTASTAIN Elite kit fromVector Labo-
ratories (Burlingame, CA). The phospho-specific-(Y705)-STAT3 rabbit anti-
body was from New England Biolabs (Beverly, MA); the anti-HA mouse
antibody from Covance, Inc. (Berkeley, CA); and the rabbit anti-b-endorphin
antibody was a kind gift from Dr. Ronnekleiv (Oregon Health and Science
University; Portland, OR) (Qiu et al., 2003). Sheep anti-a-MSH antiserum was
from Chemicon International, Inc. (Temecula, CA). The biotinylated donkey
anti-mouse antibody and the biotinylated donkey anti-rabbit antibody were
from Jackson ImmunoResearch Laboratories (West Grove, PA). Fluorescent
donkey anti-rabbit, fluorescent donkey anti-sheep, and fluorescent donkey
anti-mouse immunoglobulin conjugates were fromMolecular Probes (Eugene,
OR), and donkey serum was from Invitrogen.
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Twenty-five micrometer coronal brain sections were generated as described
earlier (Huo et al., 2006). For nonfluorescent HA IHC, brain sections were
pretreated with citrate buffer for 30 min at 80C. Sections were incubated
with anti-HA antibody (1:250) and biotinylated anti-mouse antibodies
(1:1000), followed by avidin-biotin complex labeling, and developed with
Nickel-diaminobenzidine (DAB). For double fluorescence HA and b-endorphin
IHC, sections were incubated with anti-HA (1:250) and anti-b-endorphin
(1:5000) and thenwith fluorescent-labeled (red or green) secondary antibodies.
P-STAT3 IHCwas performed as described earlier (Huo et al., 2006). For a-MSH
fluorescence IHC, sections were incubated with anti-a-MSH (1:20,000) and
fluorescent-labeled secondary antibodies generating green fluorescence.
Results were visualized using fluorescent or bright-field light and captured
withadigital camera (AxioCam,Carl Zeiss; Thornwood,NY)mountedonaZeiss
microscope (Axioscope 2). To visualize double-labeled cells, Adobe Photo-
shop software (Adobe; San Jose, CA) was used to merge fluorescence via
RGB channels. Single- and double-labeled cells were counted bilaterally in
every fifth section of one brain series and multiplied with five to obtain a total
for the entire hypothalamus, aswehavedone earlier (Huo et al., 2006).Confocal
laser scanning microscopy was performed using a Zeiss LSM510 system.
Quantification of Leptin-Induced STAT3 Phosphorylation
HA-ObRb/Pomc-Cre/Leprdb/dbandwild-type littermateswere injected i.p.with
leptin (45 min). Brain sections were subjected in parallel to double IHC for
P-STAT3 (DAB) and b-endorphin (fluorescent) (Huo et al., 2006). Digital images
were obtained with a Zeiss Axioscope. Nuclear DAB staining in POMCneurons
from three anatomically comparable brain sections from each mouse was
quantified using ImageQuant software (GE Healthcare; Piscataway, NJ). In
total, P-STAT3 was quantified in 204 random POMC neurons from wild-type
mice (n = 3) and in 234 POMC neurons from transgenic mice (n = 3).
Blood Composition, Insulin Tolerance, and Glucose Tolerance Tests
Tail vein blood was collected at 12:00 p.m. ± 2 hr from either ad libitum-fed or
fasted mice. Blood glucose was assayed with OneTouch Ultra Blood Glucose
Monitoring System (Fisher Scientific; Morrison Plains, NJ). ELISAs were used
to measure serum insulin and leptin (Crystal Chem Inc.; Downers Grove, IL)
and triglycerides (Thermo Fisher Scientific, Inc.; Waltham, MA). For insulin
tolerance tests, food was removed for 5 hr, and blood glucose concentrations
weremeasured at 15, 30, 60, 90, and 120min after i.p. injection of insulin (1.0 or
1.5 U/kg). For glucose tolerance tests, food was removed for 15 hr, and blood
glucose concentrations were measured at 15, 30, 60, 90, and 120 min after i.p.
injection of D-glucose (2 mg/g).
Pancreas Histology
Mice (11–20 weeks) were sacrificed by cervical dislocation. Pancreata were
fixed in 10% phosphate-buffered formalin and paraffin embedded. Each
pancreas was cut in serial 5 mm sections, and every 20th section was H&E
stained and analyzed. Following digital image acquisition using a CCD camera
on a Zeiss microscope, islet and exocrine areas (after exclusion of vessels and
connective tissue) were measured in each section with Adobe Photoshop and
AxioVision software. At 53magnification, 1 pixel equals 2.126 square mm. For
each pancreas, the total number of islets, total islet (endocrine) area, and total
exocrine areas were determined. The relative islet mass ([total islet area]/[total
islet area + exocrine area] 3 100) and the mean islet size (total islet area/
number of islets) were then calculated.
Oxygen Consumption and Locomotor Activity
Oxygen consumption, CO2 production, and physical activity weremeasured in
13-week-old mice using a comprehensive lab animal monitoring system
(CLAMS, Columbia Instruments; Columbus, OH). Mice were acclimated in
the monitoring chambers for 2 days followed by data collection for 3 days.
Hypothalamic Neuropeptide mRNA
Mice were euthanized by cervical dislocation. Brains were removed, arcuate-
enriched tissue isolated, and cDNA were generated as described earlier (Huo
et al., 2006). Real-time PCR was performed in a 96-well plate according to
the manufacturer’s instructions (Stratagene). The primers (Invitrogen) and
probes (Biosearch Technologies; Novato, CA) were designed with the assis-tance of Primer Express software from Applied Biosystems (Life Technologies;
Carlsbad, CA) as follows: mPOMCF (50-ACCTCACCACGGAGAGCA-30),
mPOMCR (50-GCGAGAGGTCGAGTTTGC-30), and mPOMCP (50-6-carboxy-
fluorescein [Fam]-TGCTGGCTTGCATCCGGG-BHQ-1-30); mNPYF (50-CTCC
GCTCTGCGACACTAC-30), mNPYR (50-AATCAGTGTCTCAGGGCT-30), and
mNPYP (50-6-carboxy-fluorescein [Fam]-CAATCTCATCACCAGACAG-BHQ-
1-30); mAgRPF (50-GCGGAGGTGCTAGATCCA-30), mAgRPR (50-AGGACTC
GTGCAGCCTTA-30), and mAgRPP (50-6-carboxy-fluorescein [Fam]-CGAGTC
TCGTTCTCCGCG -BHQ-1-30). PCR reactions were run in a volume of 25.0 ml
using 1.0 ml cDNA. A standard curve was generated from duplicate measure-
ments of serial dilutions of arcuate cDNA. The housekeeping gene cyclophilin
was used for normalization.
Hypothalamic Neuropeptides
The extraction and purification of the peptides from whole hypothalamic
tissues were performed as previously described (Gamber et al., 2005; Guo
et al., 2004). The samples were then assayed by enzyme immunoassays
(EIAs) fora-MSH,NPY (both in-house assays), andAgRP (Phoenix Pharmaceu-
ticals; Burlingame, CA). The sensitivities of the assays were 2, 8, and 9 pg per
sample, respectively.
Statistical Analyses
Data are presented as means ± SEM, and significance level was set at p #
0.05. Analyses were done by Student’s t tests. For insulin tolerance tests,
treatment groups were analyzed using general linear models, and individual
differences between the treatment groups were identified by one-way
ANOVA followed by the protected least significant-differences technique
(SAS version 8.2, SAS Institute; Cary, NC).
SUPPLEMENTAL DATA
Supplemental Data include six figures and can be found online at http://www.
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